116 related articles for article (PubMed ID: 36131787)
1. Oxaliplatin Induces Immunogenic Cell Death in Human and Murine Laryngeal Cancer.
Wang J; Zhang H; Yin X; Bian Y
J Oncol; 2022; 2022():3760766. PubMed ID: 36131787
[TBL] [Abstract][Full Text] [Related]
2. IL-12-Overexpressed Nanoparticles Suppress the Proliferation of Melanoma Through Inducing ICD and Activating DC, CD8
Shen HH; Peng JF; Wang RR; Wang PY; Zhang JX; Sun HF; Liang Y; Li YM; Xue JN; Li YJ; Sun GB; Xie SY
Int J Nanomedicine; 2024; 19():2755-2772. PubMed ID: 38525008
[TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin induces immunogenic cells death and enhances therapeutic efficacy of checkpoint inhibitor in a model of murine lung carcinoma.
Sun F; Cui L; Li T; Chen S; Song J; Li D
J Recept Signal Transduct Res; 2019 Jun; 39(3):208-214. PubMed ID: 31441696
[No Abstract] [Full Text] [Related]
4. In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells.
Liang W; Wang XF
Chin Med J (Engl); 2011 May; 124(9):1357-61. PubMed ID: 21740748
[TBL] [Abstract][Full Text] [Related]
5. [Effects of ulinastatin on immune function of spleen in severely burned rats and its mechanism].
Li J; Hu C; Yao Y; Yang H
Zhonghua Shao Shang Za Zhi; 2016 May; 32(5):266-71. PubMed ID: 27188484
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Cell Oncol (Dordr); 2020 Dec; 43(6):1203-1214. PubMed ID: 32797385
[TBL] [Abstract][Full Text] [Related]
7. The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.
Rodríguez-Salazar MDC; Franco-Molina MA; Mendoza-Gamboa E; Martínez-Torres AC; Zapata-Benavides P; López-González JS; Coronado-Cerda EE; Alcocer-González JM; Tamez-Guerra RS; Rodríguez-Padilla C
Oncol Lett; 2017 Jul; 14(1):844-852. PubMed ID: 28693241
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of indoleamine 2,3-dioxygenase 1 synergizes with oxaliplatin for efficient colorectal cancer therapy.
Miao X; Zhang Y; Li Z; Huang L; Xin T; Shen R; Wang T
Mol Ther Methods Clin Dev; 2021 Mar; 20():442-450. PubMed ID: 33665222
[TBL] [Abstract][Full Text] [Related]
9. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.
Fang H; Ang B; Xu X; Huang X; Wu Y; Sun Y; Wang W; Li N; Cao X; Wan T
Cell Mol Immunol; 2014 Mar; 11(2):150-9. PubMed ID: 24362470
[TBL] [Abstract][Full Text] [Related]
10. High hydrostatic pressure induces immunogenic cell death in human tumor cells.
Fucikova J; Moserova I; Truxova I; Hermanova I; Vancurova I; Partlova S; Fialova A; Sojka L; Cartron PF; Houska M; Rob L; Bartunkova J; Spisek R
Int J Cancer; 2014 Sep; 135(5):1165-77. PubMed ID: 24500981
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin and Checkpoint Inhibitor Induces Immunogenic Cells Death and Promotes Therapeutic Efficacy in the Model of Murine Triple Positive Breast Cancer.
Shi H
Stud Health Technol Inform; 2023 Nov; 308():329-340. PubMed ID: 38007757
[TBL] [Abstract][Full Text] [Related]
12. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
[TBL] [Abstract][Full Text] [Related]
13. A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model.
Mookerjee A; Graciotti M; Kandalaft LE; Kandalaft L
Bioimpacts; 2018; 8(3):211-221. PubMed ID: 30211081
[No Abstract] [Full Text] [Related]
14. Bifidobacterium Infantis Ameliorates Chemotherapy-Induced Intestinal Mucositis Via Regulating T Cell Immunity in Colorectal Cancer Rats.
Mi H; Dong Y; Zhang B; Wang H; Peter CCK; Gao P; Fu H; Gao Y
Cell Physiol Biochem; 2017; 42(6):2330-2341. PubMed ID: 28848081
[TBL] [Abstract][Full Text] [Related]
15. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells.
Liu X; Li J; Liu Y; Ding J; Tong Z; Liu Y; Zhou Y; Liu Y
Cell Immunol; 2016 Feb; 300():46-53. PubMed ID: 26702740
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells modified by tumor associated antigen SMP30 have enhanced antitumor effect against mouse hepatocarcinoma cells in vitro and in vivo.
Guo J; Zhang Y; Qin Q; Chao N; Huang T; Chen C; Lu X; Huang R; Pan J
Am J Transl Res; 2022; 14(8):5785-5799. PubMed ID: 36105050
[TBL] [Abstract][Full Text] [Related]
17. [Depressive effect of cigarette smoke extracts on dendritic cells inducing differentiation of CD4+T cells into CD4+CD25+Foxp3+ Tregs].
Liang Y; Zhou G; Zhang L; Liu J; Zhong X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):15-9. PubMed ID: 26728371
[TBL] [Abstract][Full Text] [Related]
18. Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
Zhang H; Wu J; Yuan J; Li H; Zhang Y; Wu W; Chen W; Wang C; Meng S; Chen S; Huo M; He Y; Zhang C
J Exp Clin Cancer Res; 2021 Aug; 40(1):260. PubMed ID: 34412665
[TBL] [Abstract][Full Text] [Related]
19. Oxymatrine‑mediated maturation of dendritic cells leads to activation of FOXP3+/CD4+ Treg cells and reversal of cisplatin‑resistance in lung cancer cells.
Liu H; Zou M; Li P; Wang H; Lin X; Ye J
Mol Med Rep; 2019 May; 19(5):4081-4090. PubMed ID: 30896871
[TBL] [Abstract][Full Text] [Related]
20. Derp1-modified dendritic cells attenuate allergic inflammation by regulating the development of T helper type1(Th1)/Th2 cells and regulatory T cells in a murine model of allergic rhinitis.
Yu S; Han B; Liu S; Wang H; Zhuang W; Huang Y; Zhang R
Mol Immunol; 2017 Oct; 90():172-181. PubMed ID: 28802126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]